Clinical TrialsSearch results
Number of results: 201
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Evaluation of pegaptanib and ranibizumab for macular edema secondary to retinal vein occlusion
- macular edema secondary to retinal vein occlusion
- Yamagata university,Faculty of Medicine
- 2010-04-30
Other
- Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer
- Small-cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinoma
- Thymoma/Thymic carcinoma
- Tohoku University Hospital
- 2010-03-31
Other
- Randomized Phase II Trial Comparing Docetaxel with weekly Paclitaxel and Carboplatin in Elderly Patients with Non-Small Cell Lung Cancer
- Non-small cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Randomized PhaseII study of amrubicin vs platinum-doublet re-challenge for small cell lung cancer with sensitive relapse
- Small-Cell Lung Cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Randomized clinical trial about the period of antimicrobial prophylaxis administration in hepatocellular carcinoma surgery
- Patients undergoing elective hepatocellular carcinoma surgery
- Randomized clinical trial committee, Japan Society for Surgical Infection
- 2009-12-09
Other
- Effect of middle ear pressure change on clincal symptoms in patients with endolymphatic hydrops of the inner ear
- endolymphatic hydrops
- Dept. of Otolaryngology, University of Toyama
- 2009-10-01
Other
- Japan Shunt Registry of Idiopathic Normal Pressure Hydrocephalus
- Idiopathic Normal Pressure Hydrocephalus
- Study Group for normal pressure hydrocephalus granted by the Ministry of Health, Labor and Welfare of Japan
- 2009-09-01
Other
- Effect of Meniett device on clinical symptoms in patients with endolymphatic hydrops
- endolymphatic hydrops
- Dept. of Otolaryngology, University of Toyama
- 2009-08-31
Other
- Randomized phase III trial of erlotinib versus docetaxel for patients with previously treated advanced non-small cell lung cancer
- Previously treated non-small cell lung cancer
- National Hospital Organization Headquarters Center for Support and Education of Clinical Research
- 2009-08-11